SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Akums Drugs and Pharmaceuticals informs about newspaper publication

15 Feb 2025 Evaluate
Pursuant to the Regulation 30 and 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, Akums Drugs and Pharmaceuticals has enclosed a copy of Newspaper Publications of Postal Ballot Notice published today i.e. Saturday, 15th February, 2025 in the following newspapers: 1) Business Standard, New Delhi; 2) Business Standard, New Delhi.

The above information is a part of company’s filings submitted to BSE.

Akums Drugs & Pharma Share Price

534.00 -0.10 (-0.02%)
22-Apr-2026 10:33 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1658.00
Dr. Reddys Lab 1215.05
Cipla 1228.20
Zydus Lifesciences 928.25
Lupin 2310.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×